J. Biol. Chem., Vol. 265, Issue 13, 7318-7323, 05, 1990
Expression of functional factor VIII in primary human skin fibroblasts after retrovirus-mediated gene transfer
RC Hoeben, RC van der Jagt, F Schoute, NH van Tilburg, MP Verbeet, E Briet, H van Ormondt and AJ van der Eb
Department of Medical Biochemistry, Sylvius Laboratories, Leiden, The Netherlands.
We have developed a retroviral-vector system for the transfer and
expression of a cloned blood clotting factor VIII cDNA. Since inclusion of
the complete cDNA into existing vectors is precluded by its large size, we
deleted most codons for the B-domain, which is also excised during in vivo
maturation of factor VIII. When inserted into the retroviral vector M5-neoR
(Laker, C., Stocking, C., Bergholtz, V., Hess, N., DeLamarter, J. F., and
Ostertag, W. (1987) Proc. Natl. Acad. Sci. U. S. A. 84, 8458-8462), the
sequence was shown to be efficiently expressed in murine fibroblast cell
lines, as well as in primary human skin fibroblasts. Upon infection of
murine fibroblast cell lines, clones containing only a single copy of the
integrated vector-provirus secreted up to 125 milliunits of factor VIII
antigen/10(6) cells/day. Equivalent amounts were found in a factor VIII
activity assay, which signifies that the factor VIII protein secreted by
the infected fibroblasts is fully functional. Primary human skin
fibroblasts infected with the vector virus secreted up to 30
milliunits/10(6) cells/day.